疟原虫对青蒿素耐药性的出现和传播：东南亚地区。
Origin and Spread of Evolving Artemisinin-Resistant Malarial Parasites in Southeast Asia.
机构信息
Department of Biochemistry and Cellular and Molecular Biology, Georgetown University, Washington, District of Columbia.
Department of Chemistry, Georgetown University, Washington, District of Columbia.
出版信息
Am J Trop Med Hyg. 2019 Dec;101(6):1204-1211. doi: 10.4269/ajtmh.19-0379.
Abstract
In this review, we provide an epidemiological history of the emergence and ongoing spread of evolving artemisinin resistance (ARTR). Southeast Asia has been the focal point for emergence and spread of multiple antimalarial drug resistance phenomena, and is once again for evolving ARTR, also known as the "delayed clearance phenotype" (DCP). The five countries most impacted, Cambodia, Thailand, Myanmar, Laos, and Vietnam, each have complex histories of antimalarial drug use over many decades, which have in part molded the use of various artemisinin combination therapies (ACTs) within each country. We catalog the use of ACTs, evolving loss of ACT efficacy, and the frequency of mutations (mutations associated with ARTR) in the Greater Mekong Subregion and map the historical spread of ARTR/DCP parasites. These data should assist improved surveillance and deployment of next-generation ACTs.
摘要
在这篇综述中，我们提供了青蒿素耐药性（ART）不断出现和持续传播的流行病学历史。东南亚一直是多种抗疟药物耐药现象出现和传播的焦点，也是青蒿素耐药性（也称为“清除延迟表型”（DCP））的再次出现的焦点。受影响最严重的五个国家柬埔寨、泰国、缅甸、老挝和越南，每个国家都有几十年的抗疟药物使用的复杂历史，这些历史在一定程度上塑造了每个国家对各种青蒿素联合疗法（ACT）的使用。我们列出了大湄公河次区域 ACT 的使用情况、ACT 疗效不断丧失的情况以及与 ART 相关的突变（与 ART 相关的突变）的频率，并绘制了 ARTR/DCP 寄生虫的历史传播图。这些数据应有助于改进下一代 ACT 的监测和部署。
相似文献
1
Origin and Spread of Evolving Artemisinin-Resistant Malarial Parasites in Southeast Asia.疟原虫对青蒿素耐药性的出现和传播：东南亚地区。
Am J Trop Med Hyg. 2019 Dec;101(6):1204-1211. doi: 10.4269/ajtmh.19-0379.
2
Local emergence in Amazonia of C580Y mutants associated with artemisinin resistance.在亚马逊地区出现与青蒿素耐药性相关的 C580Y 突变体。
Elife. 2020 May 12;9:e51015. doi: 10.7554/eLife.51015.
3
Geographic expansion of artemisinin resistance.青蒿素耐药性的地理扩张。
J Travel Med. 2019 Jun 1;26(4). doi: 10.1093/jtm/taz030.
4
The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study.大湄公河次区域青蒿素耐药恶性疟原虫的传播：一项分子流行病学观察性研究。
Lancet Infect Dis. 2017 May;17(5):491-497. doi: 10.1016/S1473-3099(17)30048-8. Epub 2017 Feb 2.
5
Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance.恶性疟原虫Kelch13 蛋白突变在缅甸东北部地区恶性疟原虫种群中对青蒿素耐药性的介导作用。
mBio. 2020 Feb 25;11(1):e01134-19. doi: 10.1128/mBio.01134-19.
6
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.东南亚青蒿素耐药性的临床影响及未来传播潜力。
FEMS Microbiol Rev. 2017 Jan;41(1):34-48. doi: 10.1093/femsre/fuw037. Epub 2016 Sep 8.
7
In vitro growth competition experiments that suggest consequences of the substandard artemisinin epidemic that may be accelerating drug resistance in P. falciparum malaria.体外生长竞争实验表明，青蒿素标准降低可能正在加速恶性疟原虫疟疾中的耐药性。
PLoS One. 2021 Mar 9;16(3):e0248057. doi: 10.1371/journal.pone.0248057. eCollection 2021.
8
Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study.东南亚耐多药疟疾的演变和扩散：一项基于基因组流行病学的研究。
Lancet Infect Dis. 2019 Sep;19(9):943-951. doi: 10.1016/S1473-3099(19)30392-5. Epub 2019 Jul 22.
9
Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study.大湄公河次区域抗疟药物耐药性的分子流行病学：一项观察性研究。
Lancet Infect Dis. 2020 Dec;20(12):1470-1480. doi: 10.1016/S1473-3099(20)30228-0. Epub 2020 Jul 14.
10
Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia.东南亚恶性疟原虫中青蒿素抗性突变的独立出现。
J Infect Dis. 2015 Mar 1;211(5):670-9. doi: 10.1093/infdis/jiu491. Epub 2014 Sep 1.
引用本文的文献
1
Emerging Plasmodium falciparum K13 gene mutation to artemisinin-based combination therapies and partner drugs among malaria-infected population in sub-Saharan Africa.撒哈拉以南非洲疟疾感染人群中恶性疟原虫K13基因对青蒿素联合疗法及相关药物的新出现突变
Parasites Hosts Dis. 2025 May;63(2):109-122. doi: 10.3347/PHD.24053. Epub 2025 May 26.
2
Prevalence and genetic diversity of polymorphisms in , and genes of in southern Côte d'Ivoire.科特迪瓦南部[某种疾病或研究对象]的[相关基因名称]、[相关基因名称]和[相关基因名称]基因多态性的患病率及遗传多样性
Malariaworld J. 2025 Jan 6;16:1. doi: 10.5281/zenodo.14604138. eCollection 2025.
3
Antimalarial Mechanisms and Resistance Status of Artemisinin and Its Derivatives.青蒿素及其衍生物的抗疟机制与耐药状况
Trop Med Infect Dis. 2024 Sep 20;9(9):223. doi: 10.3390/tropicalmed9090223.
4
Molecular Surveillance of Artemisinin-Resistant Parasites in Mining Areas of the Roraima Indigenous Territory in Brazil.巴西罗赖马原住民领地矿区青蒿素耐药寄生虫的分子监测
Int J Environ Res Public Health. 2024 May 25;21(6):679. doi: 10.3390/ijerph21060679.
5
A genetic cross reveals the contributions of and to piperaquine drug resistance.一次基因杂交揭示了[相关基因]对哌喹耐药性的影响。 （注：原文中“and”前面应该缺失了一些内容，这里根据语境补充了“[相关基因]”，以便使译文更通顺，但严格按照要求，应按照你提供的原文准确翻译为：一次基因杂交揭示了和对哌喹耐药性的影响。不过这样的译文不太符合正常表达习惯。）
mBio. 2024 Jul 17;15(7):e0080524. doi: 10.1128/mbio.00805-24. Epub 2024 Jun 24.
6
Characterization of antimalarial activity of artemisinin-based hybrid drugs.青蒿素类药物抗疟活性的表征。
Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0014324. doi: 10.1128/aac.00143-24. Epub 2024 Jun 20.
7
Prevalence of polymorphisms in marker genes associated with antimalarial drug resistance in following 10 years of artemisinin-based combination therapy implementation in urban Kolkata.在加尔各答市实施基于青蒿素的联合疗法10年后，与抗疟药物耐药性相关的标记基因多态性的流行情况。
Trop Parasitol. 2024 Jan-Jun;14(1):23-29. doi: 10.4103/tp.tp_43_23. Epub 2024 Feb 15.
8
Structures of Chloroquine Resistance Transporter (PfCRT) Isoforms and Their Interactions with Chloroquine.疟原虫氯通道蛋白（PfCRT）异构体的结构及其与氯喹的相互作用。
Biochemistry. 2023 Mar 7;62(5):1093-1110. doi: 10.1021/acs.biochem.2c00669. Epub 2023 Feb 17.
9
Molecular surveillance of Kelch-13 gene in Plasmodium falciparum field isolates from Mayurbhanj District, Odisha, India, and in silico artemisinin-Kelch-13 protein interaction study.印度奥里萨邦玛雅布汉杰区疟原虫野外分离株 Kelch-13 基因的分子监测及青蒿素-Kelch-13 蛋白相互作用的计算机模拟研究。
Parasitol Res. 2023 Mar;122(3):717-727. doi: 10.1007/s00436-023-07784-9. Epub 2023 Feb 2.
10
Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook.恶性疟原虫对青蒿素类复方药物的抗药性：出现、机制和展望。
Int J Parasitol Drugs Drug Resist. 2021 Aug;16:102-118. doi: 10.1016/j.ijpddr.2021.05.007. Epub 2021 May 26.
本文引用的文献
1
Molecular detection of drug resistant malaria in Southern Thailand.泰国南部地区耐药疟疾的分子检测。
Malar J. 2019 Aug 15;18(1):275. doi: 10.1186/s12936-019-2903-y.
2
Antimalarial drug resistance in Africa: the calm before the storm?非洲的抗疟药物耐药性：暴风雨前的平静？
Lancet Infect Dis. 2019 Oct;19(10):e338-e351. doi: 10.1016/S1473-3099(19)30261-0. Epub 2019 Jul 30.
3
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.中医疗法治疗失败的决定因素：柬埔寨、泰国和越南间日疟原虫疟疾的前瞻性临床、药理学和遗传学研究。
Lancet Infect Dis. 2019 Sep;19(9):952-961. doi: 10.1016/S1473-3099(19)30391-3. Epub 2019 Jul 22.
4
Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study.东南亚耐多药疟疾的演变和扩散：一项基于基因组流行病学的研究。
Lancet Infect Dis. 2019 Sep;19(9):943-951. doi: 10.1016/S1473-3099(19)30392-5. Epub 2019 Jul 22.
5
Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum.阐明耐药性疟原虫的作用机制。
Cell Host Microbe. 2019 Jul 10;26(1):35-47. doi: 10.1016/j.chom.2019.06.001.
6
Artemisinin-Based Antimalarial Drug Therapy: Molecular Pharmacology and Evolving Resistance.基于青蒿素的抗疟药物疗法：分子药理学与不断演变的耐药性
Trop Med Infect Dis. 2019 Jun 4;4(2):89. doi: 10.3390/tropicalmed4020089.
7
Clinical impact of the two ART resistance markers, K13 gene mutations and DPC3 in Vietnam.越南的两种 ART 耐药标志物（K13 基因突变和 DPC3）的临床影响。
PLoS One. 2019 Apr 2;14(4):e0214667. doi: 10.1371/journal.pone.0214667. eCollection 2019.
8
Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis.基于青蒿素的治疗后寄生虫清除率与疟原虫 falciparum Kelch13 基因（Pf3D7_1343700）突变的关联：一项 WWARN 个体患者数据荟萃分析。
BMC Med. 2019 Jan 17;17(1):1. doi: 10.1186/s12916-018-1207-3.
9
Heterogeneous distribution of k13 mutations in Plasmodium falciparum in Laos.老挝恶性疟原虫中 k13 突变的异质性分布。
Malar J. 2018 Dec 27;17(1):483. doi: 10.1186/s12936-018-2625-6.
10
Novel pfkelch13 Gene Polymorphism Associates With Artemisinin Resistance in Eastern India.新型 pfkelch13 基因突变与印度东部的青蒿素耐药性相关。
Clin Infect Dis. 2019 Sep 13;69(7):1144-1152. doi: 10.1093/cid/ciy1038.
Zotero 插件